Spark Investment Management LLC purchased a new stake in Ekso Bionics Holdings Inc (NASDAQ:EKSO) in the first quarter, HoldingsChannel.com reports. The institutional investor purchased 32,137 shares of the company’s stock, valued at approximately $80,000.
Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc boosted its position in shares of Ekso Bionics by 6.3% in the 3rd quarter. Vanguard Group Inc now owns 1,745,819 shares of the company’s stock valued at $4,085,000 after purchasing an additional 103,277 shares during the period. Vanguard Group Inc. boosted its position in shares of Ekso Bionics by 6.3% in the 3rd quarter. Vanguard Group Inc. now owns 1,745,819 shares of the company’s stock valued at $4,085,000 after purchasing an additional 103,277 shares during the period. Virtu Financial LLC boosted its position in shares of Ekso Bionics by 166.8% in the 4th quarter. Virtu Financial LLC now owns 76,376 shares of the company’s stock valued at $95,000 after purchasing an additional 47,748 shares during the period. Bailard Inc. acquired a new position in shares of Ekso Bionics in the 1st quarter valued at $63,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Ekso Bionics by 65.7% in the 4th quarter. Bank of New York Mellon Corp now owns 64,380 shares of the company’s stock valued at $79,000 after purchasing an additional 25,525 shares during the period. Institutional investors and hedge funds own 36.95% of the company’s stock.
A number of research firms recently weighed in on EKSO. Zacks Investment Research lowered Ekso Bionics from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 29th. Aegis began coverage on Ekso Bionics in a research report on Tuesday, March 26th. They issued a “buy” rating for the company.
Ekso Bionics (NASDAQ:EKSO) last announced its quarterly earnings data on Thursday, February 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.01. The firm had revenue of $3.30 million during the quarter, compared to the consensus estimate of $3.86 million. Ekso Bionics had a negative return on equity of 501.28% and a negative net margin of 206.32%.
TRADEMARK VIOLATION WARNING: “32,137 Shares in Ekso Bionics Holdings Inc (EKSO) Purchased by Spark Investment Management LLC” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/4353123/32137-shares-in-ekso-bionics-holdings-inc-ekso-purchased-by-spark-investment-management-llc.html.
About Ekso Bionics
Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke.
Read More: What are earnings reports?
Want to see what other hedge funds are holding EKSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ekso Bionics Holdings Inc (NASDAQ:EKSO).
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.